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Molecular chaperones are required for the correct folding and assembly of certain other polypeptides. It is not known whether molecular chaperones 
themselves require other chaperones to become functional. A 97-amino acid chaperone, the chaperonin 10 protein was chemically synthesised so 
that during synthesis and purification there was no contact of the chaperone with any other protein. The purified, synthetic chaperonin 10 protein 
formed oligomeric structures spontaneously and was biologically active as a chaperonin. This is the first description of a chemically synthesised 
chaperonin, and suggests that no other chaperones are required for correct folding, polymcrisation and biological activity of this chaperone. 
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1, INTRODUCTION 
Molecular chaperones, are a family of ubiquitous 
cellular proteins whose function is to prevent incorrect 
interactions between the surfaces of other molecules; 
there is evidence that chaperones are required for the 
correct folding and assembly of certain other polypep- 
tides [1,2]. This raises the question as to whether 
molecular chaperones themselves require other 
chaperones to become functional. In the yeast 
mitochondrion functional pre-existing chaperone, 
chaperonin 60 (cpn 60) [I,21 is needed so that new 
chaperonin GO can be assembled from imported 
subunits [3]. In contrast, Escherickiu co/i cpn 60 can 
self assemble [4] in the presence of Mg-ATF and is 
stimulated by chaperonin 10 (cpn 10) [5]. So far, the 
chaperones which have been studied have either been 
purified from whole cell extracts or have been made by 
recombinant DNA techniques. In both cases, the op- 
portunity is present for the chaperone protein to tran- 
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siently interact with other chaperones within the cell 
durini its folding and/or assembly. We have addressed 
this question by chemically synthesising achaperone so 
that during the synthesis and purification there was no 
contact of the chaperone with any other protein. A 
97-amino acid chaperone, the cpn 10 or 10 kDa GroES 
[5] protein of E. coli was synthesised. 
2. MATERIALS AND METHODS 
2. I. Chemical synthesis of E. coli chaperonin IO 
The synthesis of the polypeptide was carried out in a stepwise 
fashion using a 4301% ABI synthesizer and the chemical scheme based 
on the combination of N(W)-BOC, benzyl-based side chain-protected 
amino acids. Other side chain-protecting groups included: tosyl for 
Arg, dinitrophenyl (DNP) for His, Cl- and Br-carbobcnzoxy for Lys 
and Tyr, respectively. As the solid support WC used the phenylacet- 
amidomethyl resin [6) containing 0.34 mmol of Ala. All amino acids 
were double coupled using the chemical protocols developed by Kent 
[7j and the efficiency of each coupling step monitored by the qua.n- 
titative ninhydrin test [S]. The average incorporation thus calculated 
was 99.35% [9]. After the completion of chain synthesis, the DNP 
group from the His side chain was removed by treating an aliquot of 
peptide resin twice with a dimethylformamide (DMF) solution con- 
taining 2-mercaptoethanol (20% v/v) and the t-BOC group from the 
last residue with 100% TFA. 
To complete the side chain deprotection and remove the peptide 
from the resin the low-high HF procedure was used [IO]; scavengers 
utilised were dimethylsulphidc, p-cresol and pthiocresol (G:O, 8:0.2 
ml/O.5 g resin-peptide) for the low HF cleavage and p-cresol and p- 
thiocresol (0.8:O.t) during the high HF step. 
Separation of the crude, dicthylcthcr-precipitated cpn 10 from the 
peptide-resin mixture proved difficult owing to the poor solubility of 
the crude palypeptidc. Wowcver, after several washings with 5% 
acetic acid and lyophilisation of the combined solutions, 40 nig of 
crude polypeptide were obtcrlned from 200 mg of resin-peptide 
material. 
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For the refolding assay 15 mg of Iyophilised material was dissolved 
in 5 ml of 6 M urea (50 mM Tris buffer, pH 7.5) and dialysed at 4°C 
for 24 h against 4 liters of the same Tris buffer solution. 
After dialysis the solution was tested for its protein contenl using 
the Bio-Rad Protein Assay reagent, concentrated by partial 
lyophilisation ta the desired protein concentration (see below) and 
used without any further purification for the refolding assay, and for 
the FPLC and SDS-PAGE analysis. 
kDaI 
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-20 
2.2. Size-exclusion chromatography of synthetic chaperonin 10 
The separation was performed with a Pharmacia Sephacryl S-100 
column using a Pharmacia FPLC apparatus. The solvent (100 mM 
Yris-WCI, 10 mM MgC&, pH 7.8) was applied at a 2.5 ml/min eate; 
monitoring was with a UV recorder at 276 nm. 
2.3. SDS-PAGE 
SDS-PAGE analysis was performed on the Pharmacia Phast 
System with 20% gradient gels. 
2.4. Refolding of recombinant rubisco protein using synthetic 
X2. coli cpn 10 and recombinant cpn IO 
Robisco was denatured in 6 M guanidine-HCI and refolded using 
the protocol described in [1 I]. Briefly, reconstitution was initiated by 
diluting 21 ~1 denature3 rubisco into 1659 fll solution containing 50 
mM Tris-HCI buffer, pH S.0, 3 mM ATP, 7 mh4 MgC12, 20 mM 
glucose. 4pM cpn 60 and 6 ,&l cpn 10 at 23OC. At various times the 
reconstitution reaction was quenched with hexokinase. Reaction mix- 
tures were supplemented with 50 mM [‘4C]NaHCOI (300 
dpm. nmol”‘) and allowed to activate for a further 5 min. Ribulose 
biphosphate (1 mM) was added and rubisco activity measured as the 
formation of acid-stable IdC over 20 min. 
3. RESULTS AND DISCUSSION 
The purified, synthetic cpn 10 formed oligomeric 
structures which are also found in recombinant GroES 
151. The formation of oligomers was demonstrated by 
size-exclusion FPLC in non-denaturing buffer. We 
found that there were peaks at about 200 kDa 
(numbered 1 in Fig. l), 90 kDa (peak 2), 30-40 kDa 
(peak 3) and 15-30 kDa (peak 4). The 90 kDa peak 
probably corresponds to an 80 kDa oligomer described 
previously [5]. The 30--40 kDa peak may represent a 
6bKD 17KD 1KD 
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Fig, I. Sk-exclusion chromatography of synthetic ehaperonln 10, 
Fe&s 1, 2, 3 and 4 eluted at 150, 170, 225 and 245 ml, respeclively, 
In a calibration run, BSA (mol. wt. 66000) elutrd at 175 ml and 
cytoehrome c Cmal. wt, 13000) at 250 ml. 
Fig. 2. SDS-PAGE of synthetic cpn 10. (Track 1) Synthetic cpn 10 
from dialysis. (Track 2) markers. 
Time (mins) 
Fig. 3. Refolding of recombinant rublsco pro& usinp, whole, un- 
fractionated synthetic cgn 10 and recombinant cpn 60 (rubiaco 
binding protein), Rubisco refoldinp ia expressed a$ a pcrcentape of rhe 
crieymic activity of aa equal quantity of non4lenrrturcd native en- 
xytnc* 
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dimer or a trimer. On SDS-PAGE (Fig. 2), protein 
from the 30-40 kDa size-exclusion peak migrated as a 
single band at about 15 kDa, consistent with the 
previous observations with recombinant cpn 10 IS]. 
SDS-PAGE of the 90 kDa and 200 kDa peaks in the 
size-exclusion chromatography also give a single band 
at 15 kDa (data not shown). 
We then tested the synthetic protein for biological ac- 
tivity as a chaperonin. Recently Goloubinoff and col- 
Leagues [l 1 ,I%] have described an in vitro assay for cpn 
activity. Denatured recombinant rubisco protein from 
Rhodoqpirillum rubrum is biologically inactive, but in 
the presence of recombinant E. cofi cpn 10 and the 
associated cpn 60, as well as Mg-ATP and potassium 
ions, rubisco assembles in.to a dimer and regains its en- 
zymic activity. We repeated this assay with recombinant 
reagents kindly supplied to us by AA. Gatenby and G. 
Lorimer (DuPont de Nemours & Co., Wilmington, 
USA) except hat we used chemically synthesised rather 
than recombinant cpn 10. The addition of dialysed, 
complete synthetic pn 10 to denatured rubisco in the 
presence of recombinant cpn 60, Mg-ATP and 
potassium ions yielded a rubisco which was enzymically 
active as shown by the fixation of radioactive carbon 
dioxide (Fig. 3). Denatured rubisco incubated either 
alone or in the presence of either cpn 60 or cpn 10 was 
completely inactive in this assay. The synthetic pn 10 
showed comparable specific activity to that published 
for the recombinant cpn 10 [l 11. Denaturation of syn- 
thetic cpn 10 with urea, followed by dilution of the 
urea, also resulted in functionally active cpn 10. To our 
knowledge this is the first description of the chemical 
synthesis of a biologically active chaperonin. 
These experiments suggest that in the case of the cpn 
10, no other chaperones are required for correct 
folding, polymerisation and biological activity. In other 
words, unlike rubisco, the cpn 10 does not need 
chaperones to reconstruct its activity in an in vitro 
system. Although E. coli cpn 60 can self-assemble [4] it 
is not yet known whether this renatured cpn 60 is active 
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in the rubisco assay. It is unlikely that the addition of 
ci;n 60 in the rublsco assay causes the unfolded cpn 10 
to fold up correctly because the cpn 10 which was added 
was already in oligomeric form. These observations 
suggest hat the cpn 10 molecular chaperone falls into 
the category of proteins whose folding and assembEy in- 
to functional structures occurs with sufficient pro- 
bability to dispense with the services of chaperones [a]. 
Whether this is true for all chaperones remains to be 
determined. 
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